期刊文献+

普拉格雷中间体的合成工艺改进 被引量:1

An Improved Method for Synthesizing Prasugrel Intermediate
下载PDF
导出
摘要 目的对普拉格雷中间体2-溴-2-(2-氟苯基)-1-环丙基乙酮的合成工艺进行改进优化。方法以邻氟溴苄为起始原料制得的格式试剂与环丙基氰反应生成2-(2-氟苯基)-1-环丙基乙酮,再经二溴海因光照反应4h,制得抗血栓药物普拉格雷重要中间体2-溴-2-(2-氟苯基)-1-环丙基乙酮。结果该工艺采用二氯甲烷为溶剂,过氧化苯甲酰为反应促进剂,制得产物含量达到96%,产率为83.9%。结论改进后的合成方法工艺合理、可行,为工业化生产提供了实验依据。 Objective To improve and optimize the synthetic method of prasugrel intermediate 2-bromo-2-(2-fluorophenyl)-l-cyclopropylethanone. Methods A Grignard reagent, prepared by 2-fluorobenzyl bromide,was added into cyclopropanecarbonitrile to produce cyclopropyl 2-fluoro- benzyl ketone,which was then illuminated with 1,3-dibromo-5,5-dimethylhydantoin for 4 hours. The resulting product was evidenced to be 2-bromo-2-(2-fluorophenyl)-l-cyclopropylethanone. Results Methylene chloride was used as a solvent and benzoyl peroxide as a reaction accelerator. The content of the obtained product was 96 M. The productivity was 83.9 %. Conclusion The im-proved synthetic method is reasonable and feasible for the industrial production of 2-Bromo-2-(2-fluorophenyl)-l-cyclopropylethanone.
出处 《南昌大学学报(医学版)》 CAS 2013年第6期5-7,共3页 Journal of Nanchang University:Medical Sciences
基金 广东省科技计划项目(2010B031600136)
关键词 普拉格雷中间体 抗血栓药 药物合成 工艺改进 2-(2-氟苯基)-1-环丙基乙酮 prasugrel intermediate antithrombotic drug drug synthesis improvement2-bromo-2-(2-fluorophenyl)-l-cyclopropylethanone
  • 相关文献

参考文献8

  • 1Baker W L,White C M. Role of prasugrel,a novel P2Y(12)re- ceptor antagonist, in the management of acute coronary syn- dromes[J]. Am J Cardiovase Drugs,2009,9(4) :213- 229.
  • 2Farid N A,Smith R L,Gillespie T A,et al. The disposition of prasugrel,a novel thienopyridine in humans[J]. Drug Metab Dispos, 2007,35 ( 7 ) : 1096-1104.
  • 3Farid N A,Kurihara A,Wrighton S A. Metabolism and dispo- sition of the thienopyridine antiplatelet drugs ticlopidine clopi- dogrel and prasugrel in humans[J]. J Clin Pharm,2010,50(2) : 126-142.
  • 4Asai F, Jakubowski J A, Naganuma H, et al. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: A single ascending dose study in healthy humans[J]. Platelets,2006,17(4) : 209-217.
  • 5Jakunowski J A,Winters K J, Naganuma H, et al. Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct an- tiplatelet profile[J]. Cardiovascular Drug Rev, 2007, 25 (4) : 354-374.
  • 6Asai F, Ogawa T, Naganuma H, et al. Maleateaddition salt of hydropyridine derivatives : EP, 728794[P]. 2006-12-06.
  • 7Ataka K, Miyata H, Kohno M, et al. 2-Silyloxy-tetrahydrothien- opyridine,salt thereof and process forpreparing the same:US, 5874581[P]. 1997- 02 -23.
  • 8荆亚萍,申东升,邓爵安,廖伦辉.普拉格雷中间体的合成研究[J].广东药学院学报,2009,25(3):272-274. 被引量:3

二级参考文献7

共引文献2

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部